ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,416.45
-0.09%
Dow Jones
39,872.99
0.17%
Gold vs US Dollar
2,421.68
-0.20%
Brent Oil
82.445
-1.30%
Bitcoin
70,274.28
-1.65%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Citius Pharmaceuticals Inc (CTXR) Share Price

CTXR Citius Pharmaceuticals Inc

0.75
0.0902 (13.67%)
After Hours
Last Updated: 00:27:47
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Citius Pharmaceuticals Inc NASDAQ:CTXR NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.0902 13.67 0.75 0.74 0.75 0.8499 0.6705 0.78 21,683,470 23:27:47   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations  -33.69M -0.2118 -3.45 116.14M
 Type  Size  Price  Time  Units 
 20 265 0.75 23:27:47 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore CTXR News
21/05/202421:05EDGAR2Form 8-K - Current report
21/05/202412:00PRNUSCitius Pharmaceuticals Achieves Primary and Secondary Endpoints in Phase 3 Trial of Mino-Lok Antibiotic Lock Solution
14/05/202421:26EDGAR2Form 8-K - Current report
14/05/202421:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/05/202421:05PRNUSCitius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2024 Financial Results and Provides Business Update
10/05/202413:30PRNUSCitius Pharmaceuticals to Participate in Upcoming EF Hutton and H.C. Wainwright Investor Conferences
30/04/202421:05PRNUSCitius Pharmaceuticals Announces Closing of $15 Million Registered Direct Offering
Period
Draw mode
Data Downloads for CTXR

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Citius Pharmaceuticals Inc Articles